|
Magyar Sebész Társaság |
|
13th EFR Congress |
Rendezvény kezdete: 2024.04.04. | Rendezvény vége: 2024.04.06. |
Helyszín: Vienna, Austria |
A rendezvény Web oldala: http://www.efrcancer.org |
Dear Colleague,
Great news! We've extended the deadline for abstract submissions to the 13th EFR Congress, giving you more time to showcase your research to leading CRC physicians, surgeons, experts, and decision-makers in the field of Colorectal Cancer.
New Submission Date: February 29, 2024
Possible topics include, but are not limited to:
- Prevention and Screening - Imaging Techniques - Early Detection - Laparoscopic and Robot-Assisted Treatments - Metastatic Disease Management - Therapeutic Advancements - Strictures and Fistulas - Quality of Life Assessments
EFR 2024 posters will enjoy a 15% discount on their congress ticket, and will be entered into the draw for a chance to win Best Poster Award.
To submit your abstract, please send to abstract_efr2024@navus.io (PDF format)
For more information about the congress and to explore the topics and program, visit www.efrcancer.org Haven’t secured your tickets yet? Register Now |
|
|
 |
|
Magyar Sebész Társaság |
|
13th EFR Congress |
Rendezvény kezdete: 2024.04.04. | Rendezvény vége: 2024.04.06. |
Helyszín: Vienna, Austria |
A rendezvény Web oldala: http://www.efrcancer.org |
Dear Colleague,
Great news! We've extended the deadline for abstract submissions to the 13th EFR Congress, giving you more time to showcase your research to leading CRC physicians, surgeons, experts, and decision-makers in the field of Colorectal Cancer.
New Submission Date: February 29, 2024
Possible topics include, but are not limited to:
- Prevention and Screening - Imaging Techniques - Early Detection - Laparoscopic and Robot-Assisted Treatments - Metastatic Disease Management - Therapeutic Advancements - Strictures and Fistulas - Quality of Life Assessments
EFR 2024 posters will enjoy a 15% discount on their congress ticket, and will be entered into the draw for a chance to win Best Poster Award.
To submit your abstract, please send to abstract_efr2024@navus.io (PDF format)
For more information about the congress and to explore the topics and program, visit www.efrcancer.org Haven’t secured your tickets yet? Register Now |
|
|
 |
|
Magyar Dermatológiai Társulat |
|
EADO - 20th European Association of Dermato-Oncology (EADO) Congress (hybrid, Paris, France, 2024.04.04-06.) |
Rendezvény kezdete: 2024.04.04. | Rendezvény vége: 2024.04.06. |
Helyszín: France, 232;s Versailles, Paris, 10 rue de la Chancellerie, Versailles Palais des Congr& |
A rendezvény Web oldala: https://eado2024.com/ |

Dear colleagues and friends, We have the great pleasure to invite you to join us for the 20th European Association of Dermato-Oncology (EADO) Congress taking place as an on-site meeting with additional virtual access from April 4-6, 2024 in the amazing city of Paris, France. The conference provides updated scientific and clinical achievements in a wide spectrum of skin tumors including melanoma, keratinocyte carcinomas and rare malignant neoplasms. Over 1,400 participants from Europe and around the world are expected to attend. The EADO Congress is the largest conference in dermato-oncology, there are no competing meetings in this field. The world´s leading experts have been invited as speakers and will offer you the opportunity to gain a comprehensive insight into all areas of dermato-oncology. Looking forward to welcoming you online or in Versailles in April 2024!
Kind regards, Prof. Dr. Celeste Lebbé Paris, France Congress President
Prof. Dr. Claus Garbe Tuebingen, Germany Congress President
Call for Abstracts >> February 15, 2024 (6:00pm CET) Deadline for abstract submission All those interested in presenting abstracts at the 20th EADO Congress are invited to submit their work to the Programme Committee for review. Selected abstracts will be chosen for an oral presentation during the free communications sessions or as e-posters.
Registration >> , Registration fees >> Early Bird Fee On-Site Attendance until March 15, 2024 |
|
|
 |